How It Works Activates both GLP-1 and GIP receptors for a broader metabolic impact Reduces appetite and increases satiety through two hormonal pathways Enhances insulin sensitivity more aggressively than GLP-1 alone Supports reduction of visceral fat the deep abdominal fat most strongly associated with metabolic disease Improves blood sugar regulation through a dual insulin-stimulating mechanism Clinical Results In the SURMOUNT-1 trial, Tirzepatide produced average weight loss of up to 20% of body weight outperforming Semaglutide in head-to-head comparisons
I was done
At NoMi Beach Health, our medically supervised Semaglutide programs include comprehensive metabolic testing, personalized dosing protocols, nutritional guidance, and ongoing monitoring for safe, sustainable results
The track that this workout is paired with sounds like a cross between the music playing in the doctors office waiting room and the on-hold music that plays when trying to call customer service
Nausea is a side effect that tends to occur early on in treatment
This matters because both can affect appetite, fullness, digestion, and medication tolerability